JP2016509026A5 - - Google Patents

Download PDF

Info

Publication number
JP2016509026A5
JP2016509026A5 JP2015558189A JP2015558189A JP2016509026A5 JP 2016509026 A5 JP2016509026 A5 JP 2016509026A5 JP 2015558189 A JP2015558189 A JP 2015558189A JP 2015558189 A JP2015558189 A JP 2015558189A JP 2016509026 A5 JP2016509026 A5 JP 2016509026A5
Authority
JP
Japan
Prior art keywords
molecular weight
low molecular
hydrophobically modified
composition
collagen
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2015558189A
Other languages
English (en)
Japanese (ja)
Other versions
JP2016509026A (ja
JP6284956B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2014/016834 external-priority patent/WO2014130432A1/en
Publication of JP2016509026A publication Critical patent/JP2016509026A/ja
Publication of JP2016509026A5 publication Critical patent/JP2016509026A5/ja
Application granted granted Critical
Publication of JP6284956B2 publication Critical patent/JP6284956B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2015558189A 2013-02-19 2014-02-18 瘢痕組織の外観及び形成を改善するための方法並びに組成物 Active JP6284956B2 (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US201361766292P 2013-02-19 2013-02-19
US61/766,292 2013-02-19
US201361777059P 2013-03-12 2013-03-12
US61/777,059 2013-03-12
PCT/US2014/016834 WO2014130432A1 (en) 2013-02-19 2014-02-18 Methods and compositions for improving appearance and formation of scar tissue

Publications (3)

Publication Number Publication Date
JP2016509026A JP2016509026A (ja) 2016-03-24
JP2016509026A5 true JP2016509026A5 (US20040106767A1-20040603-C00005.png) 2017-02-02
JP6284956B2 JP6284956B2 (ja) 2018-02-28

Family

ID=50239982

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2015558189A Active JP6284956B2 (ja) 2013-02-19 2014-02-18 瘢痕組織の外観及び形成を改善するための方法並びに組成物

Country Status (11)

Country Link
US (1) US9084740B2 (US20040106767A1-20040603-C00005.png)
EP (1) EP2958598B1 (US20040106767A1-20040603-C00005.png)
JP (1) JP6284956B2 (US20040106767A1-20040603-C00005.png)
CN (1) CN104994889B (US20040106767A1-20040603-C00005.png)
AU (1) AU2014219132B2 (US20040106767A1-20040603-C00005.png)
BR (1) BR112015019598B1 (US20040106767A1-20040603-C00005.png)
CA (1) CA2899424A1 (US20040106767A1-20040603-C00005.png)
HK (1) HK1217453A1 (US20040106767A1-20040603-C00005.png)
MX (1) MX362459B (US20040106767A1-20040603-C00005.png)
RU (1) RU2673342C2 (US20040106767A1-20040603-C00005.png)
WO (1) WO2014130432A1 (US20040106767A1-20040603-C00005.png)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10350153B2 (en) * 2017-03-31 2019-07-16 Johnson & Johnson Consumer Inc. Topical compositions comprising retinoids and low irritation polymeric cleansing agents
US20180280275A1 (en) * 2017-03-31 2018-10-04 Johnson & Johnson Consumer Inc. Methods of Improving the Activity of Retinoids
CN107213505A (zh) * 2017-07-27 2017-09-29 南京轩凯生物科技有限公司 一种抑制瘢痕形成的γ‑聚谷氨酸和透明质酸纤维伤口敷料及其制备方法
US20210330806A1 (en) * 2020-04-23 2021-10-28 Johnson & Johnson Consumer Inc. Methods and compositions inhibiting enveloped viruses using high molecular weight hydrophobically modified alkali swellable emulsion polymers
US11690869B2 (en) * 2020-04-23 2023-07-04 Johnson & Johnson Consumer Inc. Methods of inhibiting enveloped viruses using low molecular weight hydrophobically modified polymers
US20210330701A1 (en) * 2020-04-23 2021-10-28 Johnson & Johnson Consumer Inc. Methods and compositions for inhibiting enveloped viruses using high molecular weight hydrophobically modified alkali swellable emulsion polymers and surfactant
US20210330698A1 (en) * 2020-04-23 2021-10-28 Johnson & Johnson Consumer Inc. Methods and compositions for inhibiting enveloped viruses using low molecular weight hydrophobically modified polymers
CN114099476B (zh) * 2021-11-22 2023-07-28 西安德诺海思医疗科技有限公司 一种功能性凝胶层、疤痕贴及其制备方法

Family Cites Families (45)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3755560A (en) 1971-06-30 1973-08-28 Dow Chemical Co Nongreasy cosmetic lotions
US4384096A (en) 1979-08-27 1983-05-17 The Dow Chemical Company Liquid emulsion polymers useful as pH responsive thickeners for aqueous systems
US4421769A (en) 1981-09-29 1983-12-20 The Procter & Gamble Company Skin conditioning composition
US4883864A (en) 1985-09-06 1989-11-28 Minnesota Mining And Manufacturing Company Modified collagen compound and method of preparation
CA1270996A (en) 1985-12-02 1990-06-26 Kien Van Phung Hydrophobe associative composition containing a polymer of water-soluble monomer and an amphiphilic monomer
US4943624A (en) 1988-10-28 1990-07-24 Lehigh University Supramolecular surfactants: amphiphilic polymers designed to disrupt lipid membranes
US5179190A (en) 1988-10-28 1993-01-12 Regen Steven L Supramolecular surfactants: amphiphilic polymers designed to disrupt lipid membranes
NL8900442A (nl) 1989-02-22 1990-09-17 Stichting Rega V Z W Gesulfateerde vinylpolymeren in geneesmiddelen voor het behandelen van retrovirus-infecties.
US5372807A (en) * 1990-05-14 1994-12-13 University Of Medicine And Dentistry Of New Jersey Polymers containing antifibrotic agents, compositions containing such polymers, and methods of preparation and use
US5219564A (en) * 1990-07-06 1993-06-15 Enzon, Inc. Poly(alkylene oxide) amino acid copolymers and drug carriers and charged copolymers based thereon
CA2157691C (en) 1994-09-29 1998-08-18 Joseph Doolan High performance alkali-swellable rheological additives for aqueous systems
US5874495A (en) 1994-10-03 1999-02-23 Rhodia Inc. Polymers useful as PH responsive thickeners and monomers therefor
US5719194A (en) 1995-08-22 1998-02-17 Ausimont S.P.A. Prevention and treatment of topical viral infections with perfluoropolyethers or compositions thereof
DE19626255C2 (de) 1996-06-29 1998-07-02 Juergen Prof Dr Hennig Verfahren der lokalisierten MR-Spektroskopie zur Messung überlappender Signale von gekoppelten Spinsystemen
AUPO104396A0 (en) 1996-07-17 1996-08-08 Biomolecular Research Institute Limited Antiviral linear polymers
US6060235A (en) 1997-09-19 2000-05-09 Geltex Pharmaceuticals, Inc. Antiviral polymers comprising acid functional groups and hydrophobic groups
US6060474A (en) * 1998-11-05 2000-05-09 New York Society For The Relief Of The Ruptured And Crippled Maintaining The Hospital For Special Surgery Method for preventing scar tissue formation
US7179475B1 (en) 1998-12-04 2007-02-20 Johnson & Johnson Consumer Companies, Inc. Anhydrous topical skin preparations
US6890553B1 (en) 1999-07-08 2005-05-10 Johnson & Johnson Consumer Companies, Inc. Exothermic topical delivery device
US7309688B2 (en) 2000-10-27 2007-12-18 Johnson & Johnson Consumer Companies Topical anti-cancer compositions and methods of use thereof
US6433061B1 (en) 2000-10-24 2002-08-13 Noveon Ip Holdings Corp. Rheology modifying copolymer composition
GB2369572A (en) 2000-11-29 2002-06-05 Raft Trustees Ltd Wound treatment composition comprising insulin
GB0129886D0 (en) * 2001-12-14 2002-02-06 Medtrade Products Ltd Scar management composition
US8367098B2 (en) 2002-04-30 2013-02-05 The Population Council, Inc. Unique combinations of antimicrobial compositions
US7084104B2 (en) 2003-08-28 2006-08-01 Johnson & Johnson Consumer Company Inc. Mild and effective cleansing compositions
US7098180B2 (en) 2003-08-28 2006-08-29 Johnson & Johnson Consumer Companies Inc. Mild and effective cleansing compositions
US7157414B2 (en) 2003-08-28 2007-01-02 J&J Consumer Companies, Inc. Methods of reducing irritation in personal care compositions
KR20070007201A (ko) * 2004-05-04 2007-01-12 퀸스랜드 유니버시티 오브 테크놀로지 스카 조직 치료를 위한 기능성 실록산류
US7341720B2 (en) 2005-04-06 2008-03-11 Genzyme Corporation Targeting of glycoprotein therapeutics
AU2006244386B2 (en) 2005-05-10 2011-12-22 Johnson & Johnson Consumer Companies, Inc. Low-irritation compositions and methods of making the same
EP2484657A3 (en) 2005-05-31 2013-10-02 Rhodia, Inc. Compositions having hase rheology modifiers
US7803403B2 (en) 2006-11-09 2010-09-28 Johnson & Johnson Consumer Companies, Inc. Low-irritation compositions and methods of making the same
US20100008938A1 (en) 2007-01-22 2010-01-14 Anil Diwan Self assembling amphiphilic polymers as antiviral agents
WO2008131260A1 (en) 2007-04-19 2008-10-30 Trinity Laboratories Inc. Derivatives of amyris alcohols and eudesmol for treating cold sores and herpes
US20110054375A1 (en) * 2007-11-27 2011-03-03 Hans Smola Dressing comprising polyacrylate particles and use thereof
DE102008021360A1 (de) 2008-04-29 2009-11-05 Siemens Aktiengesellschaft Verfahren und Vorrichtung zum Erkennen eines Lagerschadens
GB2470187A (en) * 2009-05-11 2010-11-17 Pharmapatents Global Ltd Captopril polymers
US8258250B2 (en) 2009-10-07 2012-09-04 Johnson & Johnson Consumer Companies, Inc. Compositions comprising superhydrophilic amphiphilic copolymers and methods of use thereof
CN102781983A (zh) 2010-03-02 2012-11-14 巴斯夫欧洲公司 阴离子性缔合流变改性剂
US8343902B2 (en) 2010-06-24 2013-01-01 Johnson & Johnson Consumer Companies, Inc. Low-irritating, clear cleansing compositions with relatively low pH
US8329627B2 (en) 2010-06-24 2012-12-11 Johnson & Johnson Consumer Companies, Inc. Low-irritating, clear cleansing compositions with relatively low pH
US8329626B2 (en) 2010-06-24 2012-12-11 Johnson & Johnson Consumer Companies, Inc. Low-irritating, clear cleansing compositions with relatively low pH
DK2563374T3 (da) 2010-07-08 2014-01-20 Devirex Ag Polyethylenglycolsammensætninger til kontrol af tilbagefald af herpes labialis, herpes genitalis og herpes zoster
US8778864B2 (en) 2010-11-15 2014-07-15 Johnson & Johnson Consumer Companies, Inc. Polyglyceryl compounds and compositions
US8338348B2 (en) 2010-12-21 2012-12-25 Johnson & Johnson Consumer Companies, Inc. Skin cleansing compositions with polyglycerol esters and hydrophobically modified polymers

Similar Documents

Publication Publication Date Title
JP2016509026A5 (US20040106767A1-20040603-C00005.png)
JP2014237817A5 (US20040106767A1-20040603-C00005.png)
EP3191546A4 (en) Emulsion polymers including one or more 1,1-disubstituted alkene compounds, emulsion methods, and polymer compositions
JP2016516880A5 (US20040106767A1-20040603-C00005.png)
EP3201768A4 (en) Programmatic event detection and message generation for requests to execute program code
MY185267A (en) Composition comprising a multistage polymer, it method of preparation and its use
JP2016135874A5 (US20040106767A1-20040603-C00005.png)
JP2017538006A5 (US20040106767A1-20040603-C00005.png)
PH12017500555A1 (en) Modified phosphpors and compositions thereof
JP2013522425A5 (US20040106767A1-20040603-C00005.png)
JP2014503607A5 (US20040106767A1-20040603-C00005.png)
JP2018511699A5 (US20040106767A1-20040603-C00005.png)
BR112016008623A2 (pt) aditivo, composição e métodos de processamento de polímero.
JP2017047613A5 (US20040106767A1-20040603-C00005.png)
JP2016534228A5 (US20040106767A1-20040603-C00005.png)
EP3183241A4 (en) Catalyst and process for producing 2,5-furandicarboxylic acid from hydromethylfurfural in water
JP2016540360A5 (ja) 基板処理システム及び基板処理方法
FR3027028B1 (fr) Produit renforce comprenant une composition a faible taux de soufre et pneumatique comprenant ledit produit renforce
JP2016540019A5 (US20040106767A1-20040603-C00005.png)
WO2015148919A3 (en) Circulating micrornas as biomarkers for endometriosis
PL3268414T3 (pl) Samonośna, biodegradowalna folia na bazie hydrofobizowanego kwasu hiauluronowego, sposób jej przygotowania i stosowania
JP2017500397A5 (US20040106767A1-20040603-C00005.png)
JP2012217972A5 (US20040106767A1-20040603-C00005.png)
JP2016054788A5 (US20040106767A1-20040603-C00005.png)
MX2016016613A (es) Composicion en forma de particulas compactadas y su uso.